Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 22Active not recruiting 9Completed 4Terminated 3Suspended 2Not yet recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 44Breast Neoplasms 33Neoplasms 31Melanoma 24Neoplasm Metastasis 22Leukemia, Myeloid, Acute 21Colorectal Neoplasms 18Prostatic Neoplasms 17Multiple Myeloma 17Lung Neoplasms 17Ovarian Neoplasms 14Myelodysplastic Syndromes 13Squamous Cell Carcinoma of Head and Neck 12Recurrence 12Lymphoma, Non-Hodgkin 12Carcinoma, Renal Cell 11Uterine Cervical Neoplasms 10Urinary Bladder Neoplasms 10Pancreatic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 10Glioblastoma 10Brain Neoplasms 10Carcinoma, Hepatocellular 9Stomach Neoplasms 8Triple Negative Breast Neoplasms 7Rectal Neoplasms 7Lymphoma 7Hodgkin Disease 7Head and Neck Neoplasms 7Glioma 7

Interventions

tazemetostat 1duvelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Lymphoma, T-Cell × 90 days × Clear all
NCT04331119 2026-05-06

Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas

Washington University School of Medicine

Phase 2 Terminated
17 enrolled
Lymphoid

Lymphoma, T-Cell

NCT05983965 2026-04-17

Study of Tazemetostat in Lymphoid Malignancies

University of Alabama at Birmingham

Phase 1 Terminated
6 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, T-Cell

NCT03590574 2026-03-16

Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma

Autolus Limited

Phase 1/2 Terminated
20 enrolled 34 charts
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡